InvestorsHub Logo
Followers 52
Posts 2230
Boards Moderated 0
Alias Born 07/06/2011

Re: Bad_Timing post# 367293

Tuesday, 07/27/2021 4:20:43 PM

Tuesday, July 27, 2021 4:20:43 PM

Post# of 402730
Brilacidin's antiviral MOA hasn't been fully elucidated yet.

The GMU researchers said at ASV 2021:

Inhibition appears to impact viral integrity in a broad-spectrum manner by interfering with viral entry and/or early post-entry steps – Post-entry mechanisms remain to be investigated



But agree, there are a few MOAs such as disrupting viral envelope, which we have been discussing here for a long while over many, many posts, for instance:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154104037

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155672448

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159230057

I'm sure there are dozens more.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News